0001127602-20-019788.txt : 20200616 0001127602-20-019788.hdr.sgml : 20200616 20200616175300 ACCESSION NUMBER: 0001127602-20-019788 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200612 FILED AS OF DATE: 20200616 DATE AS OF CHANGE: 20200616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scanlan Jacqueline CENTRAL INDEX KEY: 0001713517 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14041 FILM NUMBER: 20967484 MAIL ADDRESS: STREET 1: HAEMONETICS CORPORATION STREET 2: 400 WOOD ROAD CITY: BRAINTREE STATE: MA ZIP: 02184 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HAEMONETICS CORP CENTRAL INDEX KEY: 0000313143 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042882273 STATE OF INCORPORATION: MA FISCAL YEAR END: 0328 BUSINESS ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 7818487100 MAIL ADDRESS: STREET 1: 125 SUMMER STREET CITY: BOSTON STATE: MA ZIP: 02110 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-06-12 0000313143 HAEMONETICS CORP HAE 0001713517 Scanlan Jacqueline 125 SUMMER STREET BOSTON MA 02110 1 SVP, Global Human Resources Common Stock 2020-06-12 4 A 0 11286 0 A 17000 D Common Stock 2020-06-12 4 S 0 111 89.29 D 16889 D Common Stock 2020-06-15 4 S 0 4417 87.71 D 12472 D Common Stock 2020-06-15 4 M 0 2889 41.64 A 15361 D Common Stock 2020-06-15 4 S 0 4005 90.00 D 11356 D Common Stock 2020-06-16 4 S 0 6869 91.53 D 4487 D Non-qualified Stock Option (Right to Buy) 41.64 2020-06-15 4 M 0 2889 0 D 2020-06-06 2024-06-06 Common Stock 2889 2890 D Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020. This number includes unvested restricted stock units ("RSUs") previously reported. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Transaction pursuant to an existing 10b5-1 trading plan. Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. /s/ Thomas V. Powers, attorney-in-fact for Ms. Scanlan 2020-06-16